{"id":144929,"date":"2025-02-13T11:27:41","date_gmt":"2025-02-13T05:57:41","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=144929"},"modified":"2025-02-13T11:27:44","modified_gmt":"2025-02-13T05:57:44","slug":"pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/","title":{"rendered":"Pharma stock crashes 19% after company&#8217;s net profits decreases by 80% YoY"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-4173944286\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of pharmaceutical company, specializing in developing, manufacturing, and marketing complex products for niche therapeutic areas have declined upto 19 percent following the Q3 results with an 80 percent decline in their Profit QoQ.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3576448005\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price action<\/strong><\/h2><p>With a market capitalization of Rs. 17,764.12 crores on Thursday, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/NATCOPHARM\" target=\"_blank\" rel=\"noreferrer noopener\">Natco Pharma Limited<\/a><\/strong> down upto 19 percent making a low of Rs. 986.00 per share compared to its previous closing price of Rs. 1216.65\u00a0 per share.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened<\/strong><\/h2><p><strong>Natco Pharma Limited<\/strong> engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas has announced its Q3 results.<\/p><p>Its Revenue from operations declined by <strong>37<\/strong> percent YoY from Rs. 759 Crores in Q3FY24 to Rs. 475 Crores in Q3FY25 and it was down by <strong>65<\/strong> percent QoQ from Rs. 1,371 Crores in Q2FY25 to Rs. 475 Crores in Q3FY25.<\/p><div class=\"trade-content_5\" id=\"trade-1248845954\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Its Net Profit declined by <strong>38 <\/strong>percent&nbsp; YoY from Rs. 213 Crores in Q3FY24 to Rs. 132 Crores in Q3FY25 and it declined by <strong>80 <\/strong>percent QoQ from Rs. 676 Crores in Q2FY25 to Rs. 132 Crores in Q3FY25.<\/p><p>The earnings per share (EPS) for the quarter stood at Rs. 7.43, compared to Rs. 37.81 in the previous quarter and&nbsp; Rs. 11.88&nbsp; in the same quarter last year.<\/p><p>Furthermore, they have declared a third interim dividend of Rs. 1.50 per share (75 percent) per equity share of Rs.2 for the financial year 2024-25. The record date to determine eligible shareholders is set for 18th February 2025 and dividend payments will start from 28th February 2025.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Segment Revenue<\/strong><\/h2><p>The company\u2019s revenue is primarily driven by two segments: the Pharmaceutical segment, which contributed Rs. 459.7 crore compared to Rs. 1,356.2 crores in the previous quarter, and the Agro Chemicals segment, which contributed Rs. 15.1 crore compared to Rs. 14.9 crore in the previous quarter.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company<\/strong><\/h2><p>Natco Pharma Limited is an Indian multinational pharmaceutical company, specializing in the development, manufacturing, and marketing of generic and branded formulations. They focus on producing high-quality, affordable medicines across various therapeutic segments, including oncology, cardiology, and gastroenterology, and also engage in the production of active pharmaceutical ingredients (APIs).<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Sridhar J<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-307349073\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-2267030080\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of pharmaceutical company, specializing in developing, manufacturing, and marketing complex products for niche therapeutic areas have declined upto 19 percent following the Q3 results with an 80 percent decline in their Profit QoQ. Price action With a market capitalization of Rs. 17,764.12 crores on Thursday, the shares of Natco Pharma Limited down upto [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[18716,24978,17712,14315,6616,948,936,3157],"class_list":["post-144929","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-natco-pharma","tag-natco-pharma-latest-news-2","tag-natco-pharma-latest-news","tag-natco-pharma-share-price","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stock-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock crashes 19% after company&#039;s net profits decreases by 80% YoY - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of pharmaceutical company, specializing in developing, manufacturing, and marketing complex products for niche therapeutic areas have declined upto 19 percent following the Q3 results with an 80 percent decline in their Profit QoQ.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock crashes 19% after company&#039;s net profits decreases by 80% YoY\" \/>\n<meta property=\"og:description\" content=\"The shares of pharmaceutical company, specializing in developing, manufacturing, and marketing complex products for niche therapeutic areas have declined upto 19 percent following the Q3 results with an 80 percent decline in their Profit QoQ.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-13T05:57:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-13T05:57:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/\",\"name\":\"Pharma stock crashes 19% after company's net profits decreases by 80% YoY - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2025-02-13T05:57:41+00:00\",\"dateModified\":\"2025-02-13T05:57:44+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of pharmaceutical company, specializing in developing, manufacturing, and marketing complex products for niche therapeutic areas have declined upto 19 percent following the Q3 results with an 80 percent decline in their Profit QoQ.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock crashes 19% after company&#8217;s net profits decreases by 80% YoY\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock crashes 19% after company's net profits decreases by 80% YoY - Trade Brains Features","description":"The shares of pharmaceutical company, specializing in developing, manufacturing, and marketing complex products for niche therapeutic areas have declined upto 19 percent following the Q3 results with an 80 percent decline in their Profit QoQ.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock crashes 19% after company's net profits decreases by 80% YoY","og_description":"The shares of pharmaceutical company, specializing in developing, manufacturing, and marketing complex products for niche therapeutic areas have declined upto 19 percent following the Q3 results with an 80 percent decline in their Profit QoQ.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-02-13T05:57:41+00:00","article_modified_time":"2025-02-13T05:57:44+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/","name":"Pharma stock crashes 19% after company's net profits decreases by 80% YoY - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2025-02-13T05:57:41+00:00","dateModified":"2025-02-13T05:57:44+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of pharmaceutical company, specializing in developing, manufacturing, and marketing complex products for niche therapeutic areas have declined upto 19 percent following the Q3 results with an 80 percent decline in their Profit QoQ.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-crashes-19-after-companys-net-profits-decreases-by-80-yoy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock crashes 19% after company&#8217;s net profits decreases by 80% YoY"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=144929"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144929\/revisions"}],"predecessor-version":[{"id":144930,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144929\/revisions\/144930"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=144929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=144929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=144929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}